This dual role of PKP2 as both a genetic susceptibility factor and an acquired remodeling mediator provides novel mechanistic insights into the shared molecular underpinnings of ARVC and HF progression. This evidence concerns the gene PKP2 and arrhythmogenic right ventricular cardiomyopathy.